Poland - Pharmaceutical products
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 13 February 2019
- Opportunity publication date
- 07 January 2019
- Category
- 33600000, , , , , , ,
- Value of contract
- to be confirmed
- Your guide to exporting
Description
Adalimumabum 0,04g/0,8ml, 2 vials-450 op. 1. Ustekinumab 0,045g/0,5ml amp.teat -100 op. 1 Etanerceptum P 0.025g, 4 vials each -10 op. 2 Etanerceptum 0.01g, 4 vials each -10 op. 1 Golimumab 0,05g/0,5 ml injector -60 op. 1 Etanerceptum 0.05 g, contains 4 amp.teat. -130 op. 1 Peginterferon ALFA-2A 0.090mg/0.5ml, injection amp.-50 op. 2 Peginterferon ALFA-2A 0,180mg/0,5ml ampoule. Injection -800 op. 1 Pegaspargase 3 750j.m., 1 vial -15 op. 2 Paclitaxelum 0.1g, vial-50 op.- 3 Lenalidomide 0.01g, 21 caps each. -200 op. 4 Lenalidomide 0.015g, 21 caps.-140 op. Lenalidomide 0.025g, 21 caps each -260 op. Lenalidomide 0.005g, pack of 21 caps.-50 op.
- Opportunity closing date
- 13 February 2019
- Value of contract
- to be confirmed
About the buyer
- Address
- Samodzielny Publiczny Szpital Kliniczny nr 1 w Lublinie ul. Staszica 16 Lublin 20-081 Poland
- Contact
- dgasiorowska@spsk1.lublin.pl
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.